Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report fourth-quarter and full-year 2024 results on Feb. 4, 2025. The Zacks Consensus Estimate for fourth-quarter revenues is pegged ...
Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback program ...
After an almighty grind of over six hours, Gukesh defeated Vincent Keymer in the fifth round of the Tata Steel chess tournament in Wijk aan Zee on Wednesday. The win makes Gukesh the new India no 1 ...
Regeneron Pharmaceuticals, Inc. (REGN) Securities Class Action: The litigation is focused on the propriety of Regeneron’s statements about its compliance with applicable rules and regulations ...
SAN FRANCISCO — Just over 20 years ago, the people of California voted to spend billions of dollars on an exciting new idea to remake medicine … ...
NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ: REGN) of a class action securities ...
John Agresto is a longtime professor of politics and the retired president of St. John’s College in Santa Fe, N.M. He also serves on the Jack Miller Center Board of Directors. His latest book ...
Fianlimab is under clinical development by Regeneron Pharmaceuticals and currently in Phase I for Lymphoma. According to GlobalData, Phase I drugs for Lymphoma have a 66% phase transition success rate ...
Facilities for Regeneron Canada in thriving Mississauga/GTA biotech hub signal its growth and readiness to bring more of its life-transforming innovative medicines for serious diseases to ...
Police divers recovered the body of Vincent “Vinnie” Cornell from Lake Taupō on Monday afternoon. He has not yet been formally identified. According to a Givealittle page set up by his sister ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback